nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—Betamethasone—hematologic cancer	0.0703	0.336	CrCtD
Fluticasone Propionate—Dexamethasone—hematologic cancer	0.0703	0.336	CrCtD
Fluticasone Propionate—Triamcinolone—hematologic cancer	0.0687	0.328	CrCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0676	0.209	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0676	0.209	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0652	0.202	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0632	0.195	CiPCiCtD
Fluticasone Propionate—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0597	0.185	CiPCiCtD
Fluticasone Propionate—NR3C1—hematologic cancer	0.0531	1	CbGaD
Fluticasone Propionate—PLA2G4A—Epirubicin—hematologic cancer	0.0137	0.0853	CbGbCtD
Fluticasone Propionate—NR3C2—Betamethasone—hematologic cancer	0.0128	0.08	CbGbCtD
Fluticasone Propionate—NR3C2—Prednisolone—hematologic cancer	0.0126	0.0789	CbGbCtD
Fluticasone Propionate—SERPINA6—Triamcinolone—hematologic cancer	0.0105	0.0658	CbGbCtD
Fluticasone Propionate—SERPINA6—Prednisolone—hematologic cancer	0.00893	0.0557	CbGbCtD
Fluticasone Propionate—PGR—Betamethasone—hematologic cancer	0.00828	0.0516	CbGbCtD
Fluticasone Propionate—NR3C2—Dexamethasone—hematologic cancer	0.00745	0.0465	CbGbCtD
Fluticasone Propionate—NR3C1—Triamcinolone—hematologic cancer	0.00493	0.0307	CbGbCtD
Fluticasone Propionate—PGR—Dexamethasone—hematologic cancer	0.00481	0.03	CbGbCtD
Fluticasone Propionate—NR3C1—Betamethasone—hematologic cancer	0.00423	0.0264	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisolone—hematologic cancer	0.00417	0.026	CbGbCtD
Fluticasone Propionate—NR3C1—Prednisone—hematologic cancer	0.00394	0.0246	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00298	0.0186	CbGbCtD
Fluticasone Propionate—CYP3A7—Ifosfamide—hematologic cancer	0.00298	0.0186	CbGbCtD
Fluticasone Propionate—PGR—ovarian follicle—hematologic cancer	0.00291	0.291	CbGeAlD
Fluticasone Propionate—CYP3A7—Imatinib—hematologic cancer	0.00285	0.0178	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00285	0.0178	CbGbCtD
Fluticasone Propionate—CYP3A5—Daunorubicin—hematologic cancer	0.00279	0.0174	CbGbCtD
Fluticasone Propionate—CYP3A5—Thalidomide—hematologic cancer	0.00254	0.0159	CbGbCtD
Fluticasone Propionate—NR3C1—Dexamethasone—hematologic cancer	0.00246	0.0153	CbGbCtD
Fluticasone Propionate—CYP3A5—Teniposide—hematologic cancer	0.00243	0.0151	CbGbCtD
Fluticasone Propionate—CYP3A5—Ifosfamide—hematologic cancer	0.00224	0.014	CbGbCtD
Fluticasone Propionate—CYP3A5—Imatinib—hematologic cancer	0.00214	0.0133	CbGbCtD
Fluticasone Propionate—Fluticasone furoate—Dexamethasone—hematologic cancer	0.0021	0.0127	CrCrCtD
Fluticasone Propionate—Fluticasone furoate—Betamethasone—hematologic cancer	0.0021	0.0127	CrCrCtD
Fluticasone Propionate—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00205	0.0124	CrCrCtD
Fluticasone Propionate—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00189	0.0114	CrCrCtD
Fluticasone Propionate—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00189	0.0114	CrCrCtD
Fluticasone Propionate—CYP3A4—Bexarotene—hematologic cancer	0.00186	0.0116	CbGbCtD
Fluticasone Propionate—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00184	0.0111	CrCrCtD
Fluticasone Propionate—Difluprednate—Betamethasone—hematologic cancer	0.00183	0.011	CrCrCtD
Fluticasone Propionate—Difluprednate—Dexamethasone—hematologic cancer	0.00183	0.011	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00183	0.011	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00183	0.011	CrCrCtD
Fluticasone Propionate—Difluprednate—Triamcinolone—hematologic cancer	0.00178	0.0108	CrCrCtD
Fluticasone Propionate—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00178	0.0108	CrCrCtD
Fluticasone Propionate—CYP3A7—Irinotecan—hematologic cancer	0.00178	0.0111	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00178	0.0111	CbGbCtD
Fluticasone Propionate—CYP3A4—Lomustine—hematologic cancer	0.00173	0.0108	CbGbCtD
Fluticasone Propionate—CYP3A4—Busulfan—hematologic cancer	0.00173	0.0108	CbGbCtD
Fluticasone Propionate—CYP3A5—Dasatinib—hematologic cancer	0.00172	0.0107	CbGbCtD
Fluticasone Propionate—Fluocinonide—Dexamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Fluocinonide—Betamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Prednicarbate—Dexamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Prednicarbate—Betamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Beclomethasone—Dexamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Clocortolone—Betamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Clocortolone—Dexamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Beclomethasone—Betamethasone—hematologic cancer	0.00172	0.0104	CrCrCtD
Fluticasone Propionate—Fluocinonide—Triamcinolone—hematologic cancer	0.00168	0.0101	CrCrCtD
Fluticasone Propionate—Clocortolone—Triamcinolone—hematologic cancer	0.00168	0.0101	CrCrCtD
Fluticasone Propionate—Beclomethasone—Triamcinolone—hematologic cancer	0.00168	0.0101	CrCrCtD
Fluticasone Propionate—Prednicarbate—Triamcinolone—hematologic cancer	0.00168	0.0101	CrCrCtD
Fluticasone Propionate—Fluocortolone—Betamethasone—hematologic cancer	0.00167	0.0101	CrCrCtD
Fluticasone Propionate—Fluocortolone—Dexamethasone—hematologic cancer	0.00167	0.0101	CrCrCtD
Fluticasone Propionate—Fluocortolone—Triamcinolone—hematologic cancer	0.00163	0.00985	CrCrCtD
Fluticasone Propionate—Alclometasone—Dexamethasone—hematologic cancer	0.00162	0.0098	CrCrCtD
Fluticasone Propionate—Alclometasone—Betamethasone—hematologic cancer	0.00162	0.0098	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00162	0.0098	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00162	0.0098	CrCrCtD
Fluticasone Propionate—Prednicarbate—Prednisone—hematologic cancer	0.00159	0.00963	CrCrCtD
Fluticasone Propionate—Alclometasone—Triamcinolone—hematologic cancer	0.00158	0.00958	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00158	0.00958	CrCrCtD
Fluticasone Propionate—Amcinonide—Betamethasone—hematologic cancer	0.00158	0.00954	CrCrCtD
Fluticasone Propionate—Amcinonide—Dexamethasone—hematologic cancer	0.00158	0.00954	CrCrCtD
Fluticasone Propionate—CYP3A7—Vincristine—hematologic cancer	0.00156	0.00972	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00156	0.00972	CbGbCtD
Fluticasone Propionate—Prednicarbate—Prednisolone—hematologic cancer	0.00155	0.0094	CrCrCtD
Fluticasone Propionate—Clocortolone—Prednisolone—hematologic cancer	0.00155	0.0094	CrCrCtD
Fluticasone Propionate—Beclomethasone—Prednisolone—hematologic cancer	0.00155	0.0094	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisone—hematologic cancer	0.00155	0.00935	CrCrCtD
Fluticasone Propionate—Amcinonide—Triamcinolone—hematologic cancer	0.00154	0.00932	CrCrCtD
Fluticasone Propionate—CYP3A4—Thiotepa—hematologic cancer	0.00154	0.0096	CbGbCtD
Fluticasone Propionate—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00154	0.00929	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Betamethasone—hematologic cancer	0.00154	0.00929	CrCrCtD
Fluticasone Propionate—Diflorasone—Dexamethasone—hematologic cancer	0.00154	0.00929	CrCrCtD
Fluticasone Propionate—Flunisolide—Dexamethasone—hematologic cancer	0.00154	0.00929	CrCrCtD
Fluticasone Propionate—Flunisolide—Betamethasone—hematologic cancer	0.00154	0.00929	CrCrCtD
Fluticasone Propionate—Diflorasone—Betamethasone—hematologic cancer	0.00154	0.00929	CrCrCtD
Fluticasone Propionate—Fluocortolone—Prednisolone—hematologic cancer	0.00151	0.00913	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisone—hematologic cancer	0.0015	0.00909	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Triamcinolone—hematologic cancer	0.0015	0.00908	CrCrCtD
Fluticasone Propionate—Flunisolide—Triamcinolone—hematologic cancer	0.0015	0.00908	CrCrCtD
Fluticasone Propionate—Diflorasone—Triamcinolone—hematologic cancer	0.0015	0.00908	CrCrCtD
Fluticasone Propionate—Paramethasone—Betamethasone—hematologic cancer	0.0015	0.00906	CrCrCtD
Fluticasone Propionate—Paramethasone—Dexamethasone—hematologic cancer	0.0015	0.00906	CrCrCtD
Fluticasone Propionate—Alclometasone—Prednisolone—hematologic cancer	0.00147	0.00887	CrCrCtD
Fluticasone Propionate—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00147	0.00887	CrCrCtD
Fluticasone Propionate—Paramethasone—Triamcinolone—hematologic cancer	0.00146	0.00885	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisone—hematologic cancer	0.00146	0.00885	CrCrCtD
Fluticasone Propionate—Desoximetasone—Betamethasone—hematologic cancer	0.00146	0.00884	CrCrCtD
Fluticasone Propionate—Desoximetasone—Dexamethasone—hematologic cancer	0.00146	0.00884	CrCrCtD
Fluticasone Propionate—Desoximetasone—Triamcinolone—hematologic cancer	0.00143	0.00864	CrCrCtD
Fluticasone Propionate—Amcinonide—Prednisolone—hematologic cancer	0.00143	0.00864	CrCrCtD
Fluticasone Propionate—Triamcinolone—Betamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Mometasone—Betamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Mometasone—Dexamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Triamcinolone—Dexamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Fluorometholone—Betamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Fluorometholone—Dexamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00143	0.00863	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisone—hematologic cancer	0.00142	0.00862	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisone—hematologic cancer	0.00142	0.00862	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisone—hematologic cancer	0.00142	0.00862	CrCrCtD
Fluticasone Propionate—Betamethasone—Dexamethasone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Rimexolone—Betamethasone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Rimexolone—Dexamethasone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Dexamethasone—Betamethasone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Fluorometholone—Triamcinolone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Mometasone—Triamcinolone—hematologic cancer	0.00139	0.00843	CrCrCtD
Fluticasone Propionate—Flunisolide—Prednisolone—hematologic cancer	0.00139	0.00841	CrCrCtD
Fluticasone Propionate—Diflorasone—Prednisolone—hematologic cancer	0.00139	0.00841	CrCrCtD
Fluticasone Propionate—Clobetasol propionate—Prednisolone—hematologic cancer	0.00139	0.00841	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisone—hematologic cancer	0.00139	0.0084	CrCrCtD
Fluticasone Propionate—Rimexolone—Triamcinolone—hematologic cancer	0.00136	0.00824	CrCrCtD
Fluticasone Propionate—Dexamethasone—Triamcinolone—hematologic cancer	0.00136	0.00824	CrCrCtD
Fluticasone Propionate—Betamethasone—Triamcinolone—hematologic cancer	0.00136	0.00824	CrCrCtD
Fluticasone Propionate—Paramethasone—Prednisolone—hematologic cancer	0.00136	0.0082	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisone—hematologic cancer	0.00136	0.0082	CrCrCtD
Fluticasone Propionate—CYP3A5—Irinotecan—hematologic cancer	0.00134	0.00834	CbGbCtD
Fluticasone Propionate—Methylprednisolone—Betamethasone—hematologic cancer	0.00133	0.00807	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Dexamethasone—hematologic cancer	0.00133	0.00807	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisone—hematologic cancer	0.00132	0.008	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisone—hematologic cancer	0.00132	0.008	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00132	0.008	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisone—hematologic cancer	0.00132	0.008	CrCrCtD
Fluticasone Propionate—Desoximetasone—Prednisolone—hematologic cancer	0.00132	0.008	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Triamcinolone—hematologic cancer	0.0013	0.00788	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisone—hematologic cancer	0.00129	0.00782	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisone—hematologic cancer	0.00129	0.00782	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisone—hematologic cancer	0.00129	0.00782	CrCrCtD
Fluticasone Propionate—Mometasone—Prednisolone—hematologic cancer	0.00129	0.00781	CrCrCtD
Fluticasone Propionate—Fluorometholone—Prednisolone—hematologic cancer	0.00129	0.00781	CrCrCtD
Fluticasone Propionate—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00129	0.00781	CrCrCtD
Fluticasone Propionate—Triamcinolone—Prednisolone—hematologic cancer	0.00129	0.00781	CrCrCtD
Fluticasone Propionate—Betamethasone—Prednisolone—hematologic cancer	0.00126	0.00763	CrCrCtD
Fluticasone Propionate—Rimexolone—Prednisolone—hematologic cancer	0.00126	0.00763	CrCrCtD
Fluticasone Propionate—Dexamethasone—Prednisolone—hematologic cancer	0.00126	0.00763	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisone—hematologic cancer	0.00124	0.00748	CrCrCtD
Fluticasone Propionate—Methylprednisolone—Prednisolone—hematologic cancer	0.00121	0.0073	CrCrCtD
Fluticasone Propionate—CYP3A4—Methoxsalen—hematologic cancer	0.0012	0.00747	CbGbCtD
Fluticasone Propionate—CYP3A7—Dexamethasone—hematologic cancer	0.00117	0.00732	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00117	0.00732	CbGbCtD
Fluticasone Propionate—CYP3A5—Vincristine—hematologic cancer	0.00117	0.00729	CbGbCtD
Fluticasone Propionate—CYP3A4—Bortezomib—hematologic cancer	0.00114	0.0071	CbGbCtD
Fluticasone Propionate—CYP3A4—Daunorubicin—hematologic cancer	0.00109	0.0068	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—hematologic cancer	0.00107	0.00668	CbGbCtD
Fluticasone Propionate—CYP3A4—Cytarabine—hematologic cancer	0.00096	0.00599	CbGbCtD
Fluticasone Propionate—CYP3A4—Teniposide—hematologic cancer	0.000946	0.0059	CbGbCtD
Fluticasone Propionate—CYP3A5—Dexamethasone—hematologic cancer	0.00088	0.00549	CbGbCtD
Fluticasone Propionate—CYP3A4—Ifosfamide—hematologic cancer	0.000873	0.00545	CbGbCtD
Fluticasone Propionate—CYP3A4—Imatinib—hematologic cancer	0.000834	0.00521	CbGbCtD
Fluticasone Propionate—CYP3A4—Ruxolitinib—hematologic cancer	0.000785	0.0049	CbGbCtD
Fluticasone Propionate—CYP3A4—Nilotinib—hematologic cancer	0.000758	0.00473	CbGbCtD
Fluticasone Propionate—CYP3A4—Vinorelbine—hematologic cancer	0.000752	0.00469	CbGbCtD
Fluticasone Propionate—CYP3A4—Triamcinolone—hematologic cancer	0.000687	0.00429	CbGbCtD
Fluticasone Propionate—CYP3A4—Dasatinib—hematologic cancer	0.00067	0.00418	CbGbCtD
Fluticasone Propionate—CYP3A4—Mitoxantrone—hematologic cancer	0.000662	0.00413	CbGbCtD
Fluticasone Propionate—CYP3A4—Betamethasone—hematologic cancer	0.00059	0.00368	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisolone—hematologic cancer	0.000582	0.00363	CbGbCtD
Fluticasone Propionate—CYP3A4—Prednisone—hematologic cancer	0.00055	0.00343	CbGbCtD
Fluticasone Propionate—CYP3A4—Irinotecan—hematologic cancer	0.000521	0.00325	CbGbCtD
Fluticasone Propionate—PLA2G4A—hematopoietic system—hematologic cancer	0.000465	0.0465	CbGeAlD
Fluticasone Propionate—CYP3A4—Vinblastine—hematologic cancer	0.000463	0.00289	CbGbCtD
Fluticasone Propionate—SERPINA6—hematopoietic system—hematologic cancer	0.000463	0.0463	CbGeAlD
Fluticasone Propionate—CYP3A4—Vincristine—hematologic cancer	0.000455	0.00284	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—hematologic cancer	0.000417	0.0026	CbGbCtD
Fluticasone Propionate—NR3C2—hematopoietic system—hematologic cancer	0.000378	0.0378	CbGeAlD
Fluticasone Propionate—PGR—hematopoietic system—hematologic cancer	0.000351	0.0352	CbGeAlD
Fluticasone Propionate—CYP3A4—Dexamethasone—hematologic cancer	0.000343	0.00214	CbGbCtD
Fluticasone Propionate—PLA2G4A—Raltitrexed—Methotrexate—hematologic cancer	0.000317	0.604	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—blood—hematologic cancer	0.000308	0.0308	CbGeAlD
Fluticasone Propionate—SERPINA6—blood—hematologic cancer	0.000307	0.0307	CbGeAlD
Fluticasone Propionate—PLA2G4A—bone marrow—hematologic cancer	0.000298	0.0298	CbGeAlD
Fluticasone Propionate—SERPINA6—bone marrow—hematologic cancer	0.000297	0.0297	CbGeAlD
Fluticasone Propionate—CYP3A4—Doxorubicin—hematologic cancer	0.000285	0.00178	CbGbCtD
Fluticasone Propionate—PLA2G4A—lung—hematologic cancer	0.00027	0.027	CbGeAlD
Fluticasone Propionate—SERPINA6—lung—hematologic cancer	0.000269	0.0269	CbGeAlD
Fluticasone Propionate—PLA2G4A—testis—hematologic cancer	0.000255	0.0255	CbGeAlD
Fluticasone Propionate—NR3C2—blood—hematologic cancer	0.00025	0.0251	CbGeAlD
Fluticasone Propionate—PGR—blood—hematologic cancer	0.000233	0.0233	CbGeAlD
Fluticasone Propionate—NR3C2—lung—hematologic cancer	0.00022	0.022	CbGeAlD
Fluticasone Propionate—NR3C2—testis—hematologic cancer	0.000207	0.0207	CbGeAlD
Fluticasone Propionate—CYP3A5—hematopoietic system—hematologic cancer	0.000204	0.0204	CbGeAlD
Fluticasone Propionate—PGR—lung—hematologic cancer	0.000204	0.0204	CbGeAlD
Fluticasone Propionate—NR3C1—hematopoietic system—hematologic cancer	0.000203	0.0203	CbGeAlD
Fluticasone Propionate—PGR—testis—hematologic cancer	0.000193	0.0193	CbGeAlD
Fluticasone Propionate—PLA2G4A—lymph node—hematologic cancer	0.000185	0.0185	CbGeAlD
Fluticasone Propionate—NR3C1—gonad—hematologic cancer	0.000154	0.0154	CbGeAlD
Fluticasone Propionate—CYP3A4—hematopoietic system—hematologic cancer	0.000153	0.0153	CbGeAlD
Fluticasone Propionate—NR3C2—lymph node—hematologic cancer	0.00015	0.015	CbGeAlD
Fluticasone Propionate—PGR—lymph node—hematologic cancer	0.00014	0.014	CbGeAlD
Fluticasone Propionate—CYP3A5—blood—hematologic cancer	0.000135	0.0135	CbGeAlD
Fluticasone Propionate—NR3C1—blood—hematologic cancer	0.000134	0.0134	CbGeAlD
Fluticasone Propionate—NR3C1—bone marrow—hematologic cancer	0.00013	0.013	CbGeAlD
Fluticasone Propionate—CYP3A5—lung—hematologic cancer	0.000119	0.0119	CbGeAlD
Fluticasone Propionate—NR3C1—lung—hematologic cancer	0.000118	0.0118	CbGeAlD
Fluticasone Propionate—NR3C1—testis—hematologic cancer	0.000111	0.0111	CbGeAlD
Fluticasone Propionate—CYP3A4—blood—hematologic cancer	0.000102	0.0102	CbGeAlD
Fluticasone Propionate—NR3C1—lymph node—hematologic cancer	8.05e-05	0.00806	CbGeAlD
Fluticasone Propionate—Difluprednate—NR3C1—hematologic cancer	5.81e-05	0.0603	CrCbGaD
Fluticasone Propionate—Prednicarbate—NR3C1—hematologic cancer	5.63e-05	0.0585	CrCbGaD
Fluticasone Propionate—Clocortolone—NR3C1—hematologic cancer	5.63e-05	0.0585	CrCbGaD
Fluticasone Propionate—Diflorasone—NR3C1—hematologic cancer	5.33e-05	0.0554	CrCbGaD
Fluticasone Propionate—Desoximetasone—NR3C1—hematologic cancer	5.2e-05	0.054	CrCbGaD
Fluticasone Propionate—Flumethasone Pivalate—NR3C1—hematologic cancer	4.47e-05	0.0465	CrCbGaD
Fluticasone Propionate—Halobetasol Propionate—NR3C1—hematologic cancer	4.4e-05	0.0457	CrCbGaD
Fluticasone Propionate—Amcinonide—NR3C1—hematologic cancer	4.09e-05	0.0425	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—NR3C1—hematologic cancer	4.01e-05	0.0417	CrCbGaD
Fluticasone Propionate—Mometasone—NR3C1—hematologic cancer	3.89e-05	0.0404	CrCbGaD
Fluticasone Propionate—Rimexolone—NR3C1—hematologic cancer	3.85e-05	0.04	CrCbGaD
Fluticasone Propionate—Fluocinonide—NR3C1—hematologic cancer	3.63e-05	0.0377	CrCbGaD
Fluticasone Propionate—Beclomethasone—NR3C1—hematologic cancer	3.63e-05	0.0377	CrCbGaD
Fluticasone Propionate—Fluocinolone Acetonide—NR3C1—hematologic cancer	3.53e-05	0.0366	CrCbGaD
Fluticasone Propionate—Alclometasone—NR3C1—hematologic cancer	3.53e-05	0.0366	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—NR3C1—hematologic cancer	3.43e-05	0.0357	CrCbGaD
Fluticasone Propionate—Flunisolide—NR3C1—hematologic cancer	3.43e-05	0.0357	CrCbGaD
Fluticasone Propionate—Paramethasone—NR3C1—hematologic cancer	3.39e-05	0.0352	CrCbGaD
Fluticasone Propionate—Fluorometholone—NR3C1—hematologic cancer	3.31e-05	0.0344	CrCbGaD
Fluticasone Propionate—Methylprednisolone—NR3C1—hematologic cancer	3.2e-05	0.0332	CrCbGaD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Betamethasone—hematologic cancer	2.72e-05	0.0519	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Dexamethasone—hematologic cancer	2.72e-05	0.0519	CbGdCrCtD
Fluticasone Propionate—Triamcinolone—NR3C1—hematologic cancer	2.7e-05	0.028	CrCbGaD
Fluticasone Propionate—PLA2G4A—Betamethasone—Triamcinolone—hematologic cancer	2.66e-05	0.0508	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Triamcinolone—hematologic cancer	2.66e-05	0.0508	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisone—hematologic cancer	2.53e-05	0.0482	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisone—hematologic cancer	2.53e-05	0.0482	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Dexamethasone—Prednisolone—hematologic cancer	2.47e-05	0.047	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Betamethasone—Prednisolone—hematologic cancer	2.47e-05	0.047	CbGdCrCtD
Fluticasone Propionate—Betamethasone—NR3C1—hematologic cancer	2.21e-05	0.023	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—ABCB1—hematologic cancer	1.94e-05	0.0201	CrCbGaD
Fluticasone Propionate—Methylprednisolone—ABCB1—hematologic cancer	1.54e-05	0.016	CrCbGaD
Fluticasone Propionate—Dexamethasone—ABCG2—hematologic cancer	1.49e-05	0.0155	CrCbGaD
Fluticasone Propionate—Dexamethasone—NR3C1—hematologic cancer	1.29e-05	0.0134	CrCbGaD
Fluticasone Propionate—Betamethasone—ABCB1—hematologic cancer	1.07e-05	0.0111	CrCbGaD
Fluticasone Propionate—Malaise—Prednisone—hematologic cancer	7.24e-06	0.000132	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—hematologic cancer	7.23e-06	0.000132	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—hematologic cancer	7.23e-06	0.000132	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—hematologic cancer	7.23e-06	0.000132	CcSEcCtD
Fluticasone Propionate—Eye disorder—Methotrexate—hematologic cancer	7.21e-06	0.000131	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—hematologic cancer	7.18e-06	0.000131	CcSEcCtD
Fluticasone Propionate—Vomiting—Vincristine—hematologic cancer	7.18e-06	0.000131	CcSEcCtD
Fluticasone Propionate—Urticaria—Prednisolone—hematologic cancer	7.17e-06	0.000131	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—hematologic cancer	7.16e-06	0.00013	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Methotrexate—hematologic cancer	7.16e-06	0.00013	CcSEcCtD
Fluticasone Propionate—Rash—Vincristine—hematologic cancer	7.12e-06	0.00013	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vincristine—hematologic cancer	7.11e-06	0.00013	CcSEcCtD
Fluticasone Propionate—Pain—Triamcinolone—hematologic cancer	7.1e-06	0.000129	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—hematologic cancer	7.09e-06	0.000129	CcSEcCtD
Fluticasone Propionate—Headache—Vincristine—hematologic cancer	7.07e-06	0.000129	CcSEcCtD
Fluticasone Propionate—Nausea—Carmustine—hematologic cancer	7.03e-06	0.000128	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—hematologic cancer	7.02e-06	0.000128	CcSEcCtD
Fluticasone Propionate—Vomiting—Mitoxantrone—hematologic cancer	6.99e-06	0.000127	CcSEcCtD
Fluticasone Propionate—Vomiting—Irinotecan—hematologic cancer	6.99e-06	0.000127	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—hematologic cancer	6.98e-06	0.000127	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Methotrexate—hematologic cancer	6.97e-06	0.000127	CcSEcCtD
Fluticasone Propionate—Nausea—Alitretinoin—hematologic cancer	6.96e-06	0.000127	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Methotrexate—hematologic cancer	6.95e-06	0.000127	CcSEcCtD
Fluticasone Propionate—Hypertension—Prednisone—hematologic cancer	6.94e-06	0.000126	CcSEcCtD
Fluticasone Propionate—Rash—Mitoxantrone—hematologic cancer	6.93e-06	0.000126	CcSEcCtD
Fluticasone Propionate—Rash—Irinotecan—hematologic cancer	6.93e-06	0.000126	CcSEcCtD
Fluticasone Propionate—Dermatitis—Irinotecan—hematologic cancer	6.93e-06	0.000126	CcSEcCtD
Fluticasone Propionate—Dermatitis—Mitoxantrone—hematologic cancer	6.93e-06	0.000126	CcSEcCtD
Fluticasone Propionate—Headache—Irinotecan—hematologic cancer	6.89e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Headache—Mitoxantrone—hematologic cancer	6.89e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Nausea—Ifosfamide—hematologic cancer	6.88e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.86e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.86e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Arthralgia—Prednisone—hematologic cancer	6.84e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Triamcinolone—hematologic cancer	6.84e-06	0.000125	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Cisplatin—hematologic cancer	6.83e-06	0.000124	CcSEcCtD
Fluticasone Propionate—Anxiety—Prednisone—hematologic cancer	6.82e-06	0.000124	CcSEcCtD
Fluticasone Propionate—Vomiting—Gemcitabine—hematologic cancer	6.81e-06	0.000124	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.79e-06	0.000124	CcSEcCtD
Fluticasone Propionate—Discomfort—Prednisone—hematologic cancer	6.76e-06	0.000123	CcSEcCtD
Fluticasone Propionate—Mental disorder—Methotrexate—hematologic cancer	6.76e-06	0.000123	CcSEcCtD
Fluticasone Propionate—Rash—Gemcitabine—hematologic cancer	6.75e-06	0.000123	CcSEcCtD
Fluticasone Propionate—Dermatitis—Gemcitabine—hematologic cancer	6.75e-06	0.000123	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—hematologic cancer	6.74e-06	0.000123	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—hematologic cancer	6.74e-06	0.000123	CcSEcCtD
Fluticasone Propionate—Erythema—Methotrexate—hematologic cancer	6.71e-06	0.000122	CcSEcCtD
Fluticasone Propionate—Malnutrition—Methotrexate—hematologic cancer	6.71e-06	0.000122	CcSEcCtD
Fluticasone Propionate—Headache—Gemcitabine—hematologic cancer	6.71e-06	0.000122	CcSEcCtD
Fluticasone Propionate—Nausea—Vincristine—hematologic cancer	6.71e-06	0.000122	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—hematologic cancer	6.7e-06	0.000122	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Prednisolone—hematologic cancer	6.65e-06	0.000121	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—hematologic cancer	6.64e-06	0.000121	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—hematologic cancer	6.63e-06	0.000121	CcSEcCtD
Fluticasone Propionate—Urticaria—Triamcinolone—hematologic cancer	6.59e-06	0.00012	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—hematologic cancer	6.56e-06	0.00012	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Triamcinolone—hematologic cancer	6.56e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Oedema—Prednisone—hematologic cancer	6.56e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Prednisone—hematologic cancer	6.56e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Nausea—Mitoxantrone—hematologic cancer	6.53e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Nausea—Irinotecan—hematologic cancer	6.53e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—hematologic cancer	6.52e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Infection—Prednisone—hematologic cancer	6.51e-06	0.000119	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—hematologic cancer	6.5e-06	0.000118	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—hematologic cancer	6.47e-06	0.000118	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—hematologic cancer	6.45e-06	0.000117	CcSEcCtD
Fluticasone Propionate—Pain—Dexamethasone—hematologic cancer	6.44e-06	0.000117	CcSEcCtD
Fluticasone Propionate—Pain—Betamethasone—hematologic cancer	6.44e-06	0.000117	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Prednisone—hematologic cancer	6.43e-06	0.000117	CcSEcCtD
Fluticasone Propionate—Tachycardia—Prednisone—hematologic cancer	6.4e-06	0.000117	CcSEcCtD
Fluticasone Propionate—Skin disorder—Prednisone—hematologic cancer	6.37e-06	0.000116	CcSEcCtD
Fluticasone Propionate—Nausea—Gemcitabine—hematologic cancer	6.36e-06	0.000116	CcSEcCtD
Fluticasone Propionate—Vomiting—Cisplatin—hematologic cancer	6.35e-06	0.000116	CcSEcCtD
Fluticasone Propionate—Vision blurred—Methotrexate—hematologic cancer	6.33e-06	0.000115	CcSEcCtD
Fluticasone Propionate—Mental disorder—Epirubicin—hematologic cancer	6.32e-06	0.000115	CcSEcCtD
Fluticasone Propionate—Rash—Cisplatin—hematologic cancer	6.3e-06	0.000115	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cisplatin—hematologic cancer	6.29e-06	0.000115	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—hematologic cancer	6.28e-06	0.000114	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—hematologic cancer	6.28e-06	0.000114	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etoposide—hematologic cancer	6.26e-06	0.000114	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—hematologic cancer	6.24e-06	0.000114	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Methotrexate—hematologic cancer	6.23e-06	0.000113	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Betamethasone—hematologic cancer	6.2e-06	0.000113	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Dexamethasone—hematologic cancer	6.2e-06	0.000113	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCB1—hematologic cancer	6.2e-06	0.00644	CrCbGaD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—hematologic cancer	6.2e-06	0.000113	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.16e-06	0.000112	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Betamethasone—hematologic cancer	6.16e-06	0.000112	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Triamcinolone—hematologic cancer	6.11e-06	0.000111	CcSEcCtD
Fluticasone Propionate—Malaise—Methotrexate—hematologic cancer	6.05e-06	0.00011	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—hematologic cancer	6.05e-06	0.00011	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—hematologic cancer	6.04e-06	0.00011	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—hematologic cancer	6.03e-06	0.00011	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—hematologic cancer	6.02e-06	0.00011	CcSEcCtD
Fluticasone Propionate—Urticaria—Dexamethasone—hematologic cancer	5.98e-06	0.000109	CcSEcCtD
Fluticasone Propionate—Urticaria—Betamethasone—hematologic cancer	5.98e-06	0.000109	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.97e-06	0.000109	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisolone—hematologic cancer	5.97e-06	0.000109	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—hematologic cancer	5.97e-06	0.000109	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dexamethasone—hematologic cancer	5.95e-06	0.000108	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dexamethasone—hematologic cancer	5.95e-06	0.000108	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Betamethasone—hematologic cancer	5.95e-06	0.000108	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Betamethasone—hematologic cancer	5.95e-06	0.000108	CcSEcCtD
Fluticasone Propionate—Nausea—Cisplatin—hematologic cancer	5.93e-06	0.000108	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—hematologic cancer	5.92e-06	0.000108	CcSEcCtD
Fluticasone Propionate—Pruritus—Triamcinolone—hematologic cancer	5.87e-06	0.000107	CcSEcCtD
Fluticasone Propionate—Cough—Methotrexate—hematologic cancer	5.86e-06	0.000107	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—hematologic cancer	5.85e-06	0.000107	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—hematologic cancer	5.83e-06	0.000106	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—hematologic cancer	5.82e-06	0.000106	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—hematologic cancer	5.81e-06	0.000106	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—hematologic cancer	5.81e-06	0.000106	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—hematologic cancer	5.77e-06	0.000105	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—hematologic cancer	5.77e-06	0.000105	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—hematologic cancer	5.76e-06	0.000105	CcSEcCtD
Fluticasone Propionate—Headache—Etoposide—hematologic cancer	5.73e-06	0.000104	CcSEcCtD
Fluticasone Propionate—Arthralgia—Methotrexate—hematologic cancer	5.72e-06	0.000104	CcSEcCtD
Fluticasone Propionate—Chest pain—Methotrexate—hematologic cancer	5.72e-06	0.000104	CcSEcCtD
Fluticasone Propionate—Rash—Prednisolone—hematologic cancer	5.69e-06	0.000104	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisolone—hematologic cancer	5.68e-06	0.000104	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.68e-06	0.000103	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—hematologic cancer	5.67e-06	0.000103	CcSEcCtD
Fluticasone Propionate—Headache—Prednisolone—hematologic cancer	5.65e-06	0.000103	CcSEcCtD
Fluticasone Propionate—Discomfort—Methotrexate—hematologic cancer	5.65e-06	0.000103	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—hematologic cancer	5.59e-06	0.000102	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—hematologic cancer	5.55e-06	0.000101	CcSEcCtD
Fluticasone Propionate—Dizziness—Triamcinolone—hematologic cancer	5.49e-06	9.99e-05	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—hematologic cancer	5.48e-06	9.99e-05	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Methotrexate—hematologic cancer	5.48e-06	9.98e-05	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—hematologic cancer	5.48e-06	9.98e-05	CcSEcCtD
Fluticasone Propionate—Infection—Methotrexate—hematologic cancer	5.44e-06	9.92e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—hematologic cancer	5.43e-06	9.9e-05	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—hematologic cancer	5.42e-06	9.88e-05	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Prednisone—hematologic cancer	5.4e-06	9.84e-05	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—hematologic cancer	5.39e-06	9.82e-05	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Methotrexate—hematologic cancer	5.37e-06	9.79e-05	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Prednisone—hematologic cancer	5.36e-06	9.77e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisolone—hematologic cancer	5.36e-06	9.76e-05	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—hematologic cancer	5.35e-06	9.74e-05	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—hematologic cancer	5.35e-06	9.74e-05	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—hematologic cancer	5.34e-06	9.73e-05	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—hematologic cancer	5.33e-06	9.71e-05	CcSEcCtD
Fluticasone Propionate—Pruritus—Dexamethasone—hematologic cancer	5.33e-06	9.7e-05	CcSEcCtD
Fluticasone Propionate—Pruritus—Betamethasone—hematologic cancer	5.33e-06	9.7e-05	CcSEcCtD
Fluticasone Propionate—Skin disorder—Methotrexate—hematologic cancer	5.32e-06	9.69e-05	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.31e-06	9.68e-05	CcSEcCtD
Fluticasone Propionate—Discomfort—Epirubicin—hematologic cancer	5.28e-06	9.63e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Triamcinolone—hematologic cancer	5.28e-06	9.61e-05	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—hematologic cancer	5.24e-06	9.55e-05	CcSEcCtD
Fluticasone Propionate—Rash—Triamcinolone—hematologic cancer	5.23e-06	9.53e-05	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—hematologic cancer	5.23e-06	9.53e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Triamcinolone—hematologic cancer	5.23e-06	9.52e-05	CcSEcCtD
Fluticasone Propionate—Urticaria—Prednisone—hematologic cancer	5.21e-06	9.49e-05	CcSEcCtD
Fluticasone Propionate—Headache—Triamcinolone—hematologic cancer	5.2e-06	9.47e-05	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Prednisone—hematologic cancer	5.18e-06	9.44e-05	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Prednisone—hematologic cancer	5.18e-06	9.44e-05	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dexamethasone—hematologic cancer	5.15e-06	9.38e-05	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Betamethasone—hematologic cancer	5.15e-06	9.38e-05	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—hematologic cancer	5.14e-06	9.36e-05	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—hematologic cancer	5.13e-06	9.34e-05	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—hematologic cancer	5.13e-06	9.34e-05	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—hematologic cancer	5.09e-06	9.28e-05	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—hematologic cancer	5.07e-06	9.24e-05	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—hematologic cancer	5.03e-06	9.16e-05	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—hematologic cancer	5.02e-06	9.14e-05	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—hematologic cancer	5e-06	9.12e-05	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.99e-06	9.09e-05	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—hematologic cancer	4.98e-06	9.07e-05	CcSEcCtD
Fluticasone Propionate—Dizziness—Dexamethasone—hematologic cancer	4.98e-06	9.07e-05	CcSEcCtD
Fluticasone Propionate—Dizziness—Betamethasone—hematologic cancer	4.98e-06	9.07e-05	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—hematologic cancer	4.95e-06	9.02e-05	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—hematologic cancer	4.95e-06	9.02e-05	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—hematologic cancer	4.93e-06	8.98e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Triamcinolone—hematologic cancer	4.93e-06	8.98e-05	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.92e-06	8.95e-05	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—hematologic cancer	4.89e-06	8.91e-05	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Methotrexate—hematologic cancer	4.89e-06	8.9e-05	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—hematologic cancer	4.84e-06	8.82e-05	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Prednisone—hematologic cancer	4.83e-06	8.8e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Dexamethasone—hematologic cancer	4.79e-06	8.72e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Betamethasone—hematologic cancer	4.79e-06	8.72e-05	CcSEcCtD
Fluticasone Propionate—Rash—Betamethasone—hematologic cancer	4.75e-06	8.65e-05	CcSEcCtD
Fluticasone Propionate—Rash—Dexamethasone—hematologic cancer	4.75e-06	8.65e-05	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—hematologic cancer	4.74e-06	8.64e-05	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—hematologic cancer	4.74e-06	8.64e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Dexamethasone—hematologic cancer	4.74e-06	8.64e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Betamethasone—hematologic cancer	4.74e-06	8.64e-05	CcSEcCtD
Fluticasone Propionate—Headache—Betamethasone—hematologic cancer	4.72e-06	8.59e-05	CcSEcCtD
Fluticasone Propionate—Headache—Dexamethasone—hematologic cancer	4.72e-06	8.59e-05	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—hematologic cancer	4.71e-06	8.59e-05	CcSEcCtD
Fluticasone Propionate—Pain—Methotrexate—hematologic cancer	4.69e-06	8.53e-05	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.67e-06	8.51e-05	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—hematologic cancer	4.65e-06	8.48e-05	CcSEcCtD
Fluticasone Propionate—Pruritus—Prednisone—hematologic cancer	4.64e-06	8.45e-05	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—hematologic cancer	4.63e-06	8.43e-05	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—hematologic cancer	4.61e-06	8.39e-05	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—hematologic cancer	4.57e-06	8.33e-05	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Methotrexate—hematologic cancer	4.52e-06	8.22e-05	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Prednisone—hematologic cancer	4.49e-06	8.17e-05	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Methotrexate—hematologic cancer	4.48e-06	8.16e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Dexamethasone—hematologic cancer	4.47e-06	8.15e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Betamethasone—hematologic cancer	4.47e-06	8.15e-05	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—hematologic cancer	4.38e-06	7.99e-05	CcSEcCtD
Fluticasone Propionate—Urticaria—Methotrexate—hematologic cancer	4.35e-06	7.93e-05	CcSEcCtD
Fluticasone Propionate—Dizziness—Prednisone—hematologic cancer	4.34e-06	7.9e-05	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Methotrexate—hematologic cancer	4.33e-06	7.89e-05	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Methotrexate—hematologic cancer	4.33e-06	7.89e-05	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.32e-06	7.87e-05	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—hematologic cancer	4.23e-06	7.7e-05	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—hematologic cancer	4.23e-06	7.7e-05	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—hematologic cancer	4.19e-06	7.64e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Prednisone—hematologic cancer	4.17e-06	7.59e-05	CcSEcCtD
Fluticasone Propionate—Rash—Prednisone—hematologic cancer	4.13e-06	7.53e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Prednisone—hematologic cancer	4.13e-06	7.52e-05	CcSEcCtD
Fluticasone Propionate—Headache—Prednisone—hematologic cancer	4.11e-06	7.48e-05	CcSEcCtD
Fluticasone Propionate—Urticaria—Epirubicin—hematologic cancer	4.07e-06	7.42e-05	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—hematologic cancer	4.06e-06	7.39e-05	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—hematologic cancer	4.05e-06	7.38e-05	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—hematologic cancer	4.05e-06	7.38e-05	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Methotrexate—hematologic cancer	4.04e-06	7.35e-05	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—hematologic cancer	3.91e-06	7.12e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Prednisone—hematologic cancer	3.89e-06	7.09e-05	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.88e-06	7.07e-05	CcSEcCtD
Fluticasone Propionate—Pruritus—Methotrexate—hematologic cancer	3.88e-06	7.06e-05	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Epirubicin—hematologic cancer	3.78e-06	6.88e-05	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—hematologic cancer	3.77e-06	6.87e-05	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—hematologic cancer	3.75e-06	6.83e-05	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—hematologic cancer	3.75e-06	6.83e-05	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Methotrexate—hematologic cancer	3.75e-06	6.83e-05	CcSEcCtD
Fluticasone Propionate—Pruritus—Epirubicin—hematologic cancer	3.63e-06	6.61e-05	CcSEcCtD
Fluticasone Propionate—Dizziness—Methotrexate—hematologic cancer	3.62e-06	6.6e-05	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Epirubicin—hematologic cancer	3.51e-06	6.39e-05	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—hematologic cancer	3.5e-06	6.37e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Methotrexate—hematologic cancer	3.48e-06	6.35e-05	CcSEcCtD
Fluticasone Propionate—Rash—Methotrexate—hematologic cancer	3.45e-06	6.29e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Methotrexate—hematologic cancer	3.45e-06	6.29e-05	CcSEcCtD
Fluticasone Propionate—Headache—Methotrexate—hematologic cancer	3.43e-06	6.25e-05	CcSEcCtD
Fluticasone Propionate—Dizziness—Epirubicin—hematologic cancer	3.39e-06	6.18e-05	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—hematologic cancer	3.36e-06	6.11e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Epirubicin—hematologic cancer	3.26e-06	5.94e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Methotrexate—hematologic cancer	3.25e-06	5.93e-05	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—hematologic cancer	3.25e-06	5.91e-05	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—hematologic cancer	3.23e-06	5.89e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—hematologic cancer	3.23e-06	5.88e-05	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—hematologic cancer	3.21e-06	5.85e-05	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—hematologic cancer	3.14e-06	5.71e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Epirubicin—hematologic cancer	3.05e-06	5.55e-05	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—hematologic cancer	3.02e-06	5.49e-05	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—hematologic cancer	2.99e-06	5.45e-05	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—hematologic cancer	2.99e-06	5.44e-05	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—hematologic cancer	2.97e-06	5.41e-05	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—hematologic cancer	2.82e-06	5.13e-05	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KITLG—hematologic cancer	1.96e-06	8.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NQO1—hematologic cancer	1.96e-06	8.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CD44—hematologic cancer	1.96e-06	8.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALOX5—hematologic cancer	1.96e-06	8.79e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TERT—hematologic cancer	1.94e-06	8.72e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT5A—hematologic cancer	1.92e-06	8.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—hematologic cancer	1.9e-06	8.55e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—hematologic cancer	1.9e-06	8.53e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDGFB—hematologic cancer	1.9e-06	8.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NUP98—hematologic cancer	1.9e-06	8.51e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3R1—hematologic cancer	1.88e-06	8.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HDC—hematologic cancer	1.86e-06	8.37e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TSC2—hematologic cancer	1.85e-06	8.32e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYCS—hematologic cancer	1.85e-06	8.32e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—hematologic cancer	1.84e-06	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	1.84e-06	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADCY7—hematologic cancer	1.84e-06	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOA3—hematologic cancer	1.84e-06	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD86—hematologic cancer	1.84e-06	8.25e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NUP214—hematologic cancer	1.83e-06	8.21e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—JAK2—hematologic cancer	1.83e-06	8.2e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HES1—hematologic cancer	1.81e-06	8.13e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NCOR1—hematologic cancer	1.8e-06	8.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCG2—hematologic cancer	1.79e-06	8.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTR—hematologic cancer	1.79e-06	8.04e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGFR3—hematologic cancer	1.78e-06	8.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—hematologic cancer	1.78e-06	8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CSF2—hematologic cancer	1.78e-06	8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF1—hematologic cancer	1.78e-06	8e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK14—hematologic cancer	1.77e-06	7.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ENO2—hematologic cancer	1.76e-06	7.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FOXO1—hematologic cancer	1.76e-06	7.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFRB—hematologic cancer	1.75e-06	7.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CB—hematologic cancer	1.73e-06	7.79e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ESR1—hematologic cancer	1.73e-06	7.78e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFRA—hematologic cancer	1.72e-06	7.74e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRKCG—hematologic cancer	1.72e-06	7.72e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAK1—hematologic cancer	1.72e-06	7.72e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FN1—hematologic cancer	1.71e-06	7.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CDA—hematologic cancer	1.7e-06	7.65e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—hematologic cancer	1.7e-06	7.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTT1—hematologic cancer	1.7e-06	7.65e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BAD—hematologic cancer	1.69e-06	7.59e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NFKBIA—hematologic cancer	1.69e-06	7.59e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.68e-06	7.53e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—hematologic cancer	1.67e-06	7.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SDC1—hematologic cancer	1.66e-06	7.48e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	1.66e-06	7.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PC—hematologic cancer	1.64e-06	7.37e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD80—hematologic cancer	1.64e-06	7.36e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—hematologic cancer	1.64e-06	7.35e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KIT—hematologic cancer	1.64e-06	7.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTP1—hematologic cancer	1.63e-06	7.33e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTPN11—hematologic cancer	1.61e-06	7.22e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2RA—hematologic cancer	1.61e-06	7.21e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—hematologic cancer	1.6e-06	7.18e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—hematologic cancer	1.59e-06	7.15e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—hematologic cancer	1.59e-06	7.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GBA—hematologic cancer	1.58e-06	7.12e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.58e-06	7.12e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—hematologic cancer	1.58e-06	7.08e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK14—hematologic cancer	1.57e-06	7.05e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CREB1—hematologic cancer	1.56e-06	7e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFB—hematologic cancer	1.55e-06	6.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—hematologic cancer	1.55e-06	6.94e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ESR1—hematologic cancer	1.54e-06	6.91e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—hematologic cancer	1.54e-06	6.91e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL2—hematologic cancer	1.52e-06	6.85e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6R—hematologic cancer	1.52e-06	6.83e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CREBBP—hematologic cancer	1.52e-06	6.82e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TSC2—hematologic cancer	1.51e-06	6.8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—hematologic cancer	1.51e-06	6.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—hematologic cancer	1.5e-06	6.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NCOR1—hematologic cancer	1.5e-06	6.74e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—hematologic cancer	1.49e-06	6.68e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CREBBP—hematologic cancer	1.48e-06	6.66e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGFR3—hematologic cancer	1.46e-06	6.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTAP—hematologic cancer	1.45e-06	6.51e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAP2K1—hematologic cancer	1.45e-06	6.5e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK14—hematologic cancer	1.44e-06	6.48e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—hematologic cancer	1.44e-06	6.46e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—hematologic cancer	1.42e-06	6.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NQO1—hematologic cancer	1.42e-06	6.36e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CD44—hematologic cancer	1.42e-06	6.36e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ESR1—hematologic cancer	1.41e-06	6.35e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—hematologic cancer	1.41e-06	6.31e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FN1—hematologic cancer	1.4e-06	6.27e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—hematologic cancer	1.39e-06	6.23e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—hematologic cancer	1.39e-06	6.22e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFKBIA—hematologic cancer	1.38e-06	6.2e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BAD—hematologic cancer	1.38e-06	6.2e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGF2—hematologic cancer	1.38e-06	6.19e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—hematologic cancer	1.37e-06	6.14e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3R1—hematologic cancer	1.36e-06	6.1e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CREBBP—hematologic cancer	1.35e-06	6.06e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD80—hematologic cancer	1.34e-06	6.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYCS—hematologic cancer	1.34e-06	6.01e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KIT—hematologic cancer	1.34e-06	6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—hematologic cancer	1.34e-06	6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—hematologic cancer	1.34e-06	6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.33e-06	5.98e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3R1—hematologic cancer	1.33e-06	5.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—hematologic cancer	1.33e-06	5.96e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JAK2—hematologic cancer	1.32e-06	5.93e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTPN11—hematologic cancer	1.31e-06	5.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FHL2—hematologic cancer	1.29e-06	5.8e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—hematologic cancer	1.29e-06	5.79e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—hematologic cancer	1.28e-06	5.75e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CREB1—hematologic cancer	1.27e-06	5.72e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AGRN—hematologic cancer	1.27e-06	5.69e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—hematologic cancer	1.26e-06	5.64e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—hematologic cancer	1.25e-06	5.63e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MTOR—hematologic cancer	1.25e-06	5.63e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL2—hematologic cancer	1.25e-06	5.59e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6R—hematologic cancer	1.24e-06	5.58e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CREBBP—hematologic cancer	1.24e-06	5.57e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—hematologic cancer	1.23e-06	5.5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMMR—hematologic cancer	1.2e-06	5.39e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH2—hematologic cancer	1.2e-06	5.39e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAP2K1—hematologic cancer	1.18e-06	5.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.18e-06	5.3e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—hematologic cancer	1.18e-06	5.29e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—hematologic cancer	1.18e-06	5.28e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—hematologic cancer	1.15e-06	5.18e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—hematologic cancer	1.15e-06	5.17e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—hematologic cancer	1.15e-06	5.17e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.13e-06	5.07e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF2—hematologic cancer	1.13e-06	5.05e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—hematologic cancer	1.12e-06	5.04e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JUN—hematologic cancer	1.12e-06	5.03e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.12e-06	5.02e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—hematologic cancer	1.11e-06	5e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3R1—hematologic cancer	1.11e-06	4.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CA9—hematologic cancer	1.1e-06	4.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACP5—hematologic cancer	1.1e-06	4.93e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—hematologic cancer	1.09e-06	4.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.08e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.08e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.08e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—hematologic cancer	1.08e-06	4.87e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAK2—hematologic cancer	1.08e-06	4.84e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK8—hematologic cancer	1.06e-06	4.76e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—hematologic cancer	1.06e-06	4.75e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—hematologic cancer	1.06e-06	4.75e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—hematologic cancer	1.05e-06	4.73e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—hematologic cancer	1.03e-06	4.64e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CREBBP—hematologic cancer	1.03e-06	4.64e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—IDH1—hematologic cancer	1.03e-06	4.64e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MTOR—hematologic cancer	1.02e-06	4.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—hematologic cancer	1.02e-06	4.6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.02e-06	4.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.02e-06	4.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TXN—hematologic cancer	1.02e-06	4.59e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—hematologic cancer	1.01e-06	4.53e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—hematologic cancer	1.01e-06	4.51e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SPHK1—hematologic cancer	9.99e-07	4.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—hematologic cancer	9.8e-07	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—hematologic cancer	9.79e-07	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—hematologic cancer	9.78e-07	4.39e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—hematologic cancer	9.69e-07	4.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—hematologic cancer	9.67e-07	4.34e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—hematologic cancer	9.67e-07	4.34e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—hematologic cancer	9.62e-07	4.32e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—hematologic cancer	9.61e-07	4.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.6e-07	4.31e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—hematologic cancer	9.59e-07	4.31e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—hematologic cancer	9.42e-07	4.23e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—hematologic cancer	9.41e-07	4.23e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—hematologic cancer	9.36e-07	4.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.34e-07	4.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.34e-07	4.19e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—hematologic cancer	9.26e-07	4.16e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3R1—hematologic cancer	9.25e-07	4.15e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—hematologic cancer	9.17e-07	4.12e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JUN—hematologic cancer	9.15e-07	4.11e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.1e-07	4.09e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—hematologic cancer	9.01e-07	4.04e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—hematologic cancer	8.99e-07	4.03e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—hematologic cancer	8.87e-07	3.98e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—hematologic cancer	8.85e-07	3.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NUP98—hematologic cancer	8.82e-07	3.96e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK8—hematologic cancer	8.66e-07	3.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—hematologic cancer	8.64e-07	3.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.56e-07	3.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.56e-07	3.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—hematologic cancer	8.54e-07	3.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NUP214—hematologic cancer	8.5e-07	3.82e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—hematologic cancer	8.44e-07	3.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTR—hematologic cancer	8.33e-07	3.74e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.33e-07	3.74e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—hematologic cancer	8.32e-07	3.74e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—hematologic cancer	8.23e-07	3.7e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—hematologic cancer	8.21e-07	3.69e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENO2—hematologic cancer	8.16e-07	3.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—hematologic cancer	8.06e-07	3.62e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—hematologic cancer	8.01e-07	3.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—hematologic cancer	8e-07	3.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTT1—hematologic cancer	7.92e-07	3.56e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—hematologic cancer	7.92e-07	3.56e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—hematologic cancer	7.9e-07	3.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SDC1—hematologic cancer	7.74e-07	3.48e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—hematologic cancer	7.65e-07	3.43e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—hematologic cancer	7.57e-07	3.4e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—hematologic cancer	7.47e-07	3.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CREBBP—hematologic cancer	7.47e-07	3.35e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—hematologic cancer	7.4e-07	3.32e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—hematologic cancer	7.38e-07	3.31e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—hematologic cancer	7.36e-07	3.3e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—hematologic cancer	7.34e-07	3.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—hematologic cancer	7.08e-07	3.18e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—hematologic cancer	7.07e-07	3.18e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—hematologic cancer	7.04e-07	3.16e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—hematologic cancer	6.99e-07	3.14e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—hematologic cancer	6.8e-07	3.05e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—hematologic cancer	6.77e-07	3.04e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3R1—hematologic cancer	6.69e-07	3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NQO1—hematologic cancer	6.58e-07	2.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CD44—hematologic cancer	6.58e-07	2.96e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—hematologic cancer	6.25e-07	2.8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—hematologic cancer	6.25e-07	2.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYCS—hematologic cancer	6.23e-07	2.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.19e-07	2.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—hematologic cancer	6.17e-07	2.77e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—hematologic cancer	6.1e-07	2.74e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—hematologic cancer	6.04e-07	2.71e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—hematologic cancer	5.78e-07	2.6e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—hematologic cancer	5.55e-07	2.49e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—hematologic cancer	5.53e-07	2.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.49e-07	2.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—hematologic cancer	5.33e-07	2.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—hematologic cancer	5.21e-07	2.34e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.2e-07	2.33e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—hematologic cancer	5.1e-07	2.29e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—hematologic cancer	5.09e-07	2.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.04e-07	2.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.04e-07	2.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.46e-07	2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—hematologic cancer	4.25e-07	1.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—hematologic cancer	3.76e-07	1.69e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.75e-07	1.68e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.47e-07	1.56e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.29e-07	1.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—hematologic cancer	3.25e-07	1.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.11e-07	1.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—hematologic cancer	3.07e-07	1.38e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.87e-07	1.29e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—hematologic cancer	2.48e-07	1.11e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—hematologic cancer	2.37e-07	1.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.75e-07	7.86e-06	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—hematologic cancer	1.43e-07	6.42e-06	CbGpPWpGaD
